Evidence map›Paper›PMID 31690935›Full record

Observational studyNeurosurgery2020

Metastatic Spine Disease: Should Patients With Short Life Expectancy Be Denied Surgical Care? An International Retrospective Cohort Study.

Nicolas Dea, Anne L Versteeg, Arjun Sahgal, Jorrit-Jan Verlaan, Raphaële Charest-Morin, Laurence D Rhines, Daniel M Sciubba, James M Schuster, Michael H Weber, Aron Lazary and 8 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Quality of life in patients with malignant spinal cord compression: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  2. Review
  3. Article
  4. Impact of complications on survival after surgery for metastatic spinal cord compression.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  5. Article
  6. Regional variability and economic impact on surgical practices for metastatic spinal disease in Europe - a survey on spine surgeons.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. More help than harm: surgery for metastatic spinal cord compression is associated with more favorable overall survival within a propensity score analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Nicolas DeaDivision of Spine Surgery, Department of Orthopaedics, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
Anne L VersteegDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The Netherlands.
Arjun SahgalDepartment of Radiation Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada.
Jorrit-Jan VerlaanDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The Netherlands.
Raphaële Charest-MorinDivision of Spine Surgery, Department of Orthopaedics, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
Laurence D RhinesMD Anderson Cancer Center, Department of Neurosurgery, The University of Texas, Houston, Texas.
Daniel M SciubbaDepartment of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
James M SchusterDepartment of Neurosurgery, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania.
Michael H WeberDivision of Surgery, Montreal General Hospital, McGill University, Montreal, Canada.
Aron LazaryNational Center for Spinal Disorders, Buda Health Center, Budapest, Hungary.
Michael G FehlingsSpine Program, Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University of Toronto, Toronto, Canada.
Michelle J ClarkeDepartment of Neurosurgery, Mayo Clinic, Rochester, Minnesota.
Paul M ArnoldDepartment of Neurosurgery, The University of Kansas Hospital, The University of Kansas, Kansas City, Kansas.
Stefano BorianiIRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
Chetan BettegowdaDepartment of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Ilya LauferDepartment of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Ziya L GokaslanDepartment of Neurosurgery, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Brown University, Providence, Rhode Island.
Charles G FisherDivision of Spine Surgery, Department of Orthopaedics, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundDespite our inability to accurately predict survival in many cancer patients, a life expectancy of at least 3 mo is historically necessary to be considered for surgical treatment of spinal metastases.

objectiveTo compare health-related quality of life (HRQOL) in patients surviving <3 mo after surgical treatment to patients surviving >3 mo to assess the validity of this inclusion criteria.

methodsPatients who underwent surgery for spinal metastases between August 2013 and May 2017 were retrospectively identified from an international cohort study. HRQOL was evaluated using generic and disease-specific outcome tools at baseline and at 6 and 12 wk postsurgery. The primary outcome was the HRQOL at 6 wk post-treatment measured by the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ).

resultsA total of 253 patients were included: 40 patients died within the first 3 mo after surgery and 213 patients survived more than 3 mo. Patients surviving <3 mo after surgery presented with lower baseline performance status. Adjusted analyses for baseline performance status did not reveal a significant difference in HRQOL between both groups at 6 wk post-treatment. No significant difference in patient satisfaction at 6 wk with regard to their treatment could be detected between both groups.

conclusionWhen controlled for baseline performance status, quality of life 6 wk after surgery for spinal metastasis is independent of survival. To optimize improvement in HRQOL for this patient population, baseline performance status should take priority over expected survival in the surgical decision-making process.

Indexed as

Life ExpectancyQuality of LifeTreatment OutcomeAgedCohort StudiesFemaleHumansMaleMiddle AgedOutcome Assessment, Health CarePatient SatisfactionRetrospective StudiesSpinal NeoplasmsSurveys and QuestionnairesHealth-related quality of lifeLife expectancyMetastatic spine diseaseSurgical care

Identifiers

PMID31690935
PMCPMC7360875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.